a1 Department of Life Sciences, University of Limerick, Limerick, Ireland
a2 Bundesanstalt für Milchforschung, Institut für Chemie und Physik, Kiel, Germany
Numerous casein and whey protein-derived angiotensin-I-converting enzyme (ACE) inhibitory peptides/hydrolysates have been identified. Clinical trials in hypertensive animals and humans show that these peptides/hydrolysates can bring about a significant reduction in hypertension. These peptides/hydrolysates may be classified as functional food ingredients and nutraceuticals due to their ability to provide health benefits i.e. as functional food ingredients in reducing the risk of developing a disease and as nutraceuticals in the prevention/treatment of disease.
c1 * Corresponding author: R. J. FitzGerald